Applied DNA Sciences Inc (NAS:APDN)
$ 3.5558 -0.1842 (-4.93%) Market Cap: 3.07 Mil Enterprise Value: 1.09 Mil PE Ratio: 0 PB Ratio: 0.58 GF Score: 50/100

Q3 2020 Applied DNA Sciences Inc Earnings Call Transcript

Aug 06, 2020 / 08:30PM GMT
Release Date Price: $219.4 (+3.49%)
Operator

Good day, and welcome to the Applied DNA Sciences Fiscal Third Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please note that today's event is being recorded.

I would now like to turn the conference over to Sanjay Hurry, Executive Director, Investor Relations. Please go ahead.

Sanjay M. Hurry
Applied DNA Sciences, Inc. - Executive Director of IR & Corporate Communications

Thank you, Jordan. Good afternoon, everyone, and welcome to Applied DNA's conference call to discuss our fiscal third quarter 2020 business updates and financial results. You can access the press release that was issued after market close today and slide presentation accompanying this call by going to the Investors section of our website. Speaking on the call today are Dr. James Hayward, our CEO; and Beth Jantzen, our CFO.

Before we begin, please note that some of the information you will hear today during our discussion may consist of forward-looking statements. I refer you to Slide 2 of the presentation and the company's Form 10-K filed on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot